Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Wall Street analysts change outlook on top names. Check analyst ratings page for all changes. See wh

Wall Street analysts made some dramatic moves on Thursday, slashing price targets by double digits o

Stifel analyst Stephen Willey initiates coverage on Lyell Immunopharma (NASDAQ:LYEL) with a Buy r

B. Riley Securities analyst Yuan Zhi initiates coverage on Lyell Immunopharma (NASDAQ:LYEL) with

Lyell Immunopharma, Inc. (NASDAQ: LYEL - Get Free Report) has received an average rating of "Moderat

Gainers Seer (NASDAQ:SEER) shares rose 32.1% to $2.14 during Monday's pre-market session. The m

The average of price targets set by Wall Street analysts indicates a potential upside of 176% in Lye

SOUTH SAN FRANCISCO, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYE

Citizens analyst Reni J. Benjamin reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Market Outpe

Lyell Immunopharma (LYLE) offers asymmetric upside, with ronde-cel showing best-in-class durability

Lyell Immunopharma, Inc. (NASDAQ:LYEL), a late-stage clinical company advancing a pipeline of next-g

More than 100 patients treated with ronde-cel in 2L and 3L+ LBCL, with a manufacturing success rate

Lyell Immunopharma, Inc. (LYEL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Lyell Immunopharma (NASDAQ:LYEL) wi

on Lyell Immunopharma Inc. (NASDAQ: LYEL) stock is up on Monday as the company is providing an updat

Lyell Immunopharma reports improved safety data for LYL273 in metastatic colorectal cancer and advan

Gastrointestinal prophylaxis reduced Grade ≥ 2 diarrhea/colitis from 55% without prophylaxis to 10%

SOUTH SAN FRANCISCO, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYE

Lyell Immunopharma, Inc. (NASDAQ:LYEL), a late-stage clinical company advancing a pipeline of next-g

SOUTH SAN FRANCISCO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYE

Lyell Immunopharma (LYEL) is technically in oversold territory now, so the heavy selling pressure mi

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Lyell Immunopharma (NASDAQ:LYEL) wi

SOUTH SAN FRANCISCO, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYE

Lyell Immunopharma NASDAQ: LYEL President and CEO Lynn Seely outlined the company's clinical develop

Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

Lyell Immunopharma, Inc. (LYEL) Presents at H.C. Wainwright 4th Annual BioConnect Investor Conferenc

Lyell Immunopharma (LYEL) is technically in oversold territory now, so the heavy selling pressure mi

SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(1.10) per share which beat the analy

PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line se

Lyell Immunopharma, Inc. (NASDAQ: LYEL - Get Free Report) was the recipient of a significant increas

Wall Street analysts changed outlook on top stocks. See rating changes on NKE, SMPL, WSR, NTNX, and

Top Wall Street analysts changed outlook on top names. Initiations & upgrades noted. For full ch

Needham analyst Gil Blum initiates coverage on Lyell Immunopharma (NASDAQ:LYEL) with a Buy rating

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the compan

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of Bla

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.